MedTrace Logo

Willebrand International Non-interventional Global Surveillance

NCT01949220 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2018-08-08

No results posted yet for this study

Summary

Collect information about WILLFACT or WILFACTIN in their real life clinical use and identify the therapeutic practices in an international environment.

Conditions

  • Von Willebrand Disease

Sponsors & Collaborators

  • Laboratoire français de Fractionnement et de Biotechnologies

    lead INDUSTRY

Principal Investigators

  • Wolfgang MIESBACH, Dr · Medizinische Klinik III, Goethe Universitat, D-60590 Frankfurt/Main (Germany)

  • Flora PEYVANDI, Prof. · Faculty of Medicine, University of Milan, 20122 Milan (Italy)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Belgium
  • Czechia
  • Finland
  • Germany
  • Greece
  • Italy
  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01949220 on ClinicalTrials.gov